Results 121 to 130 of about 3,632,413 (364)

Longitudinal predictors of weapon involvement in middle adolescence: Evidence from the UK Millennium Cohort Study

Aggressive Behavior, Volume 49, Issue 1, Page 5-14, January 2023., 2023
Abstract This study uses longitudinal data from the UK Millennium Cohort Study (N = 13,277) to examine the childhood and early adolescence factors that predict weapon involvement in middle adolescence, which in this study is exemplified by having carried or used a weapon.
Aase Villadsen, Emla Fitzsimons
wiley   +1 more source

Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.

Archives of Internal Medicine, 2009
BACKGROUND We sought to provide a contemporary picture of the presentation, etiology, and outcome of infective endocarditis (IE) in a large patient cohort from multiple locations worldwide.
D. Murdoch, G. Corey, B. Hoen, J. Miró, V. Fowler, A. Bayer, A. Karchmer, L. Olaison, P. Pappas, P. Moreillon, S. Chambers, V. Chu, V. Falcó, D. Holland, P. Jones, J. Klein, N. Raymond, K. Read, M. Tripodi, R. Utili, Andrew Wang, C. Woods, C. Cabell   +22 more
semanticscholar   +1 more source

Polyfunctional CD8+CD226+RUNX2hi effector T cells are diminished in advanced stages of chronic lymphocytic leukemia

Molecular Oncology, EarlyView.
CD226+CD8+ T cells express elevated levels of RUNX2, exhibit higher proliferation capacity, cytokines and cytolytic molecules expression, and migratory capacity. In contrast, CD226−CD8+ T cells display an exhausted phenotype associated with the increased expression of co‐inhibitory receptors and impaired effector functions.
Maryam Rezaeifar, Shima Shahbaz, Anthea C. Peters, Spencer B. Gibson, Shokrollah Elahi   +4 more
wiley   +1 more source

Factors modulating 99mTc‐MAA planar lung dosimetry for 90Y radioembolization

Journal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022
Abstract Purpose To investigate the accuracy and biases of predicted lung shunt fraction (LSF) and lung dose (LD) calculations via 99mTc‐macro‐aggregated albumin (99mTc‐MAA) planar imaging for treatment planning of 90Y‐microsphere radioembolization.
Benjamin P. Lopez, Armeen Mahvash, James P. Long, Marnix G. E. H. Lam, S. Cheenu Kappadath   +4 more
wiley   +1 more source

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

The Lancet, 2023
Chaolin Huang, Lixue Huang, Ye-ming Wang, Xia Li, L. Ren, Xiaoying Gu, Liang Kang, Li Guo, Min Liu, Xing Zhou, Jianfeng Luo, Zhenghui Huang, Shengjin Tu, Yue Zhao, Li Chen, Decui Xu, Yanping Li, Caihong Li, Lu Peng, Yong Li, Wuxiang Xie, D. Cui, L. Shang, Guohui Fan, Jiuyang Xu, Geng Wang, Ying Wang, J. Zhong, Chen Wang, Jianwei Wang, Dingyu Zhang, B. Cao   +31 more
semanticscholar   +1 more source

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

Annals of Clinical and Translational Neurology, 2018
The Parkinson's Progression Markers Initiative (PPMI) is an observational, international study designed to establish biomarker‐defined cohorts and identify clinical, imaging, genetic, and biospecimen Parkinson's disease (PD) progression markers to ...
K. Marek, S. Chowdhury, A. Siderowf, Shirley Lasch, C. Coffey, C. Caspell-Garcia, T. Simuni, D. Jennings, C. Tanner, J. Trojanowski, L. Shaw, J. Seibyl, N. Schuff, A. Singleton, K. Kieburtz, A. Toga, B. Mollenhauer, D. Galasko, L. Chahine, D. Weintraub, T. Foroud, D. Tosun-Turgut, K. Poston, V. Arnedo, M. Frasier, T. Sherer, S. Bressman, M. Merchant, W. Poewe, C. Kopil, A. Naito, R. Dorsey, C. Casaceli, N. Daegele, J. Albani, L. Uribe, Eric D. Foster, J. Long, N. Seedorff, K. Crawford, Danielle Smith, P. Casalin, G. Malferrari, C. Halter, L. Heathers, D. Russell, S. Factor, P. Hogarth, A. Amara, R. Hauser, J. Jankovic, M. Stern, Shu‐Ching Hu, Gretchen Todd, R. Saunders-Pullman, I. Richard, H. Saint‐Hilaire, K. Seppi, H. Shill, Hubert H. Fernandez, C. Trenkwalder, W. Oertel, D. Berg, Kathrin Brockman, I. Wurster, L. Rosenthal, Yen F. Tai, N. Pavese, P. Barone, S. Isaacson, A. Espay, D. Rowe, M. Brandabur, J. Tetrud, G. Liang, Á. Iranzo, E. Tolosa, K. Marder, Maria de Sanchez, L. Stefanis, M. Marti, J. Martínez, J. Corvol, O. Assly, Salima Brillman, Nir Giladi, Debra Smejdir, Julia Pelaggi, F. Kausar, L. Rees, Barbara Sommerfield, Madeline Cresswell, C. Blair, Karen Williams, Grace A. Zimmerman, S. Guthrie, Ashlee Rawlins, Leigh Donharl, C. Hunter, B. Tran, A. Darin, Heli A. Venkov, Cathi A Thomas, Raymond James, B. Heim, Paul Deritis, F. Sprenger, D. Raymond, D. Willeke, Zoran Obradov, J. Mule, Nancy Monahan, K. Gauss, D. Fontaine, D. Szpak, Arita McCoy, Becky Dunlop, Laura Payne, Susan Ainscough, L. Carvajal, Rebecca Silverstein, Kristy J. Espay, Madelaine B. Rañola, E. Rezola, H. Santana, M. Stamelou, Alicia Garrido, S. Carvalho, G. Kristiansen, Krista Specketer, Anat Mirlman, M. Facheris, H. Soares, A. Mintun, J. Cedarbaum, Peggy Taylor, L. Slieker, Brian McBride, Colin Watson, Etienne Montagut, Z. Sheikh, Baris Bingol, R. Forrat, P. Sardi, T. Fischer, D. Reith, J. Egebjerg, L. Larsen, N. Breysse, D. Meulien, B. Saba, V. Kiyasova, C. Min, Thomas McAvoy, R. Umek, P. Iredale, J. Edgerton, Demetrio Santi, C. Czech, F. Boess, J. Sevigny, T. Kremer, I. Grachev, K. Merchant, A. Avbersek, P. Muglia, Alexandra Stewart, R. Prashad, Johannes Taucher   +168 more
semanticscholar   +1 more source

Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer

Molecular Oncology, EarlyView.
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia, Anouk C. de Jong, Lisanne F. van Dessel, Vanja de Weerd, Corine Beaufort, Jean Helmijr, José Alberto Nakauma‐González, Job van Riet, Paul Hamberg, Daniel Vis, Michiel S. van der Heijden, Nick Beije, Martijn P. Lolkema, Teoman Deger, Saskia M. Wilting, Ronald de Wit, Maurice P. H. M. Jansen, John W. M. Martens   +17 more
wiley   +1 more source

Uniqueness of radiomic features in non‐small cell lung cancer

Journal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022
Abstract Purpose The uniqueness of radiomic features, combined with their reproducibility, determines the reliability of radiomic studies. This study is to test the hypothesis that radiomic features extracted from a defined region of interest (ROI) are unique to the underlying structure (e.g., tumor). Approach Two cohorts of non‐small cell lung cancer (
Gary Ge, Jie Zhang
wiley   +1 more source

Cohort Profile: The Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort

International Journal of Epidemiology, 2012
Summary The Avon Longitudinal Study of Children and Parents (ALSPAC) was established to understand how genetic and environmental characteristics influence health and development in parents and children.
A. Fraser, C. Macdonald-Wallis, K. Tilling, A. Boyd, J. Golding, G. Davey Smith, J. Henderson, J. Macleod, Lynn Molloy, A. Ness, S. Ring, S. Nelson, D. Lawlor   +12 more
semanticscholar   +1 more source

Integration of single‐cell and bulk RNA‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer

Molecular Oncology, EarlyView.
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley   +1 more source